Despite recent sharp criticism and a $650 million settlement, hundreds of thousands of consumers with atrial fibrillation continue to take the blood thinner.
from Well http://well.blogs.nytimes.com/2014/08/18/weighing-pradaxas-risks/
from Well http://well.blogs.nytimes.com/2014/08/18/weighing-pradaxas-risks/
No comments:
Post a Comment